Related Experiment Videos
Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function
N Udagawa1, N Takahashi, H Yasuda
1Department of Biochemistry, School of Dentistry, Showa University, Tokyo, Japan.
Abstract:
Osteoprotegerin (OPG), a soluble decoy receptor for receptor activator of nuclear factor-kappaB ligand (RANKL)/osteoclast differentiation factor, inhibits both differentiation and function of osteoclasts. We previously reported that OPG-deficient mice exhibited severe osteoporosis caused by enhanced osteoclastic bone resorption. In the present study, potential roles of OPG in osteoclast differentiation were examined using a mouse coculture system of calvarial osteoblasts and bone marrow cells prepared from OPG-deficient mice. In the absence of bone-resorbing factors, no osteoclasts were formed in cocultures of wild-type (+/+) or heterozygous (+/-) mouse-derived osteoblasts with bone marrow cells prepared from homozygous (-/-) mice. In contrast, homozygous (-/-) mouse-derived osteoblasts strongly supported osteoclast formation in the cocultures with homozygous (-/-) bone marrow cells, even in the absence of bone-resorbing factors. Addition of OPG to the cocultures with osteoblasts and bone marrow cells derived from homozygous (-/-) mice completely inhibited spontaneously occurring osteoclast formation. Adding 1alpha,25-dihydroxyvitamin D3 [1alpha,25(OH)2D3] to these cocultures significantly enhanced osteoclast differentiation. In addition, bone-resorbing activity in organ cultures of fetal long bones derived from homozygous (-/-) mice was markedly increased, irrespective of the presence and absence of bone-resorbing factors, in comparison with that from wild-type (+/+) mice. Osteoblasts prepared from homozygous (-/-), heterozygous (+/-), and wild-type (+/+) mice constitutively expressed similar levels of RANKL messenger RNA, which were equally increased by the treatment with 1alpha,25(OH)2D3. When homozygous (-/-) mouse-derived osteoblasts and hemopoietic cells were cocultured, but direct contact between them was prevented, no osteoclasts were formed, even in the presence of 1alpha,25(OH)2D3 and macrophage colony-stimulating factor. These findings suggest that OPG produced by osteoblasts/stromal cells is a physiologically important regulator in osteoclast differentiation and function and that RANKL expressed by osteoblasts functions as a membrane-associated form.
Insights
Osteoprotegerin (OPG) is crucial for regulating osteoclast differentiation and function. OPG deficiency leads to enhanced bone resorption and osteoporosis, highlighting its role in maintaining bone health.
Area of Science:
- Bone Biology
- Cellular and Molecular Medicine
- Endocrinology
Background:
- Osteoprotegerin (OPG) is a key inhibitor of osteoclast differentiation and function.
- OPG deficiency in mice results in severe osteoporosis due to increased osteoclastic bone resorption.
- The precise role of OPG in osteoclast differentiation requires further investigation.
Purpose of the Study:
- To examine the potential roles of OPG in osteoclast differentiation.
- To investigate the mechanism by which OPG regulates osteoclast formation.
- To clarify the function of RANKL expressed by osteoblasts.
Main Methods:
- Utilized a mouse coculture system with calvarial osteoblasts and bone marrow cells from OPG-deficient mice.
- Assessed osteoclast formation in the absence and presence of bone-resorbing factors.
- Analyzed RANKL messenger RNA expression and bone-resorbing activity in organ cultures.
Main Results:
- OPG-deficient osteoblasts strongly supported spontaneous osteoclast formation.
- Addition of OPG completely inhibited spontaneous osteoclast formation in OPG-deficient cocultures.
- RANKL expressed by osteoblasts acts as a membrane-associated factor, essential for osteoclast differentiation.
Conclusions:
- Osteoprotegerin (OPG) produced by osteoblasts/stromal cells is a critical physiological regulator of osteoclast differentiation and function.
- Receptor activator of nuclear factor-kappaB ligand (RANKL) expressed by osteoblasts functions as a membrane-associated form.
- These findings underscore the importance of the OPG/RANKL system in bone homeostasis.